Product identification
Medicine name:
Nafpenzal DC Suspensie voor intramammair gebruik
Nafpenzal DC Suspension intramammaire
Nafpenzal DC Suspension zur intramammären Anwendung
Active substance:
- Benzylpenicillin procaine
- Dihydrostreptomycin sulfate
- Nafcillin sodium
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Benzylpenicillin procaine300.00milligram(s)3.00gram(s)
-
Dihydrostreptomycin sulfate125.00milligram(s)3.00gram(s)
-
Nafcillin sodium109.00milligram(s)3.00gram(s)
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle
-
Meat and offal5week
-
Milkno withdrawal periodTreatment to calving interval ≥ 46 days: 48 hours; Treatment to calving interval < 46 days: 46 days after treatment.
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RC23
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Package description:
- Nafpenzal DC 100 Intramammary syringes with 3 g of Intramammary suspension
- Nafpenzal DC 6 x 20 Intramammary syringes with 3g of Intramammary suspension
- Nafpenzal DC 20 Intramammary syringes with 3g of Intramammary suspension
- Nafpenzal DC 5 x 4 Intramammary syringes with 3g of Intramammary suspension
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Authorisation number:
- BE-V023572
Date of authorisation status change:
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.